KV
Insider
Kristiina MD Vuori
DirectorKristiina MD Vuori (Director) filed 1 Form 4 report in the past 24 months (1 purchase, 0 sales), most often in Inhibrx Biosciences, Inc. (INBX). Across 1 priced purchase filing, the average 21-session return was +4.9% from execution and +5.3% from disclosure (delay-adjusted; derived). The largest single filing was $100K of INBX (6,667 sh × $15.00, as filed), executed Oct 3 2024.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
+4.9%
avg across 1 priced filings
Delay-adjustediThe same average, entered at disclosure dates
+5.3%
same 1 filings, from disclosure
Filings, ttm
1
1 buys · 0 sells
Median delay
4d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$100K
shares × price, as filed
Last traded
Oct 3 2024
Filed Oct 7 2024
Median ADV $33.6M across their filed names
Open performance→Volume by month
Buys $100K
Sells $0
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 24 months
Most traded names
INBX
Inhibrx Biosciences, Inc.
INBX · 1 buy · 0 sells
1 filing
Recent filings
INBXPURCHASE
Inhibrx Biosciences, Inc.
View filing →
$100K6,667 sh × $15.00
Exec Oct 3 2024
Filed Oct 7 2024 · 5:30 PM ET